Reproducibility of lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with locally advanced rectal cancer (original ) (raw )The Impact of Neutrophil to Lymphocytic Ratio (NLR) as a Predictor of Treatment Outcomes in Rectal Carcinomas: A Retrospective Cohort Study
Amal Ibrahim
Journal of Cancer Therapy
View PDFchevron_right
Çakmak E, Soylu S, Yönem Ö, Yılmaz A. Neutrophil-toLymphocyte Ratio, Plateletto-Lymphocyte Ratio, and Red Blood Cell Distribution Width as New Biomarkers in Patients with Colorectal Cancer. Erciyes Med J 2017; 39: 131-6.
Journal of Clinical Practice and Research
Erciyes Medical Journal, 2017
View PDFchevron_right
Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients
Lucjan Wyrwicz
Biology, 2022
View PDFchevron_right
The role of ‘neutrophil-to-lymphocyte ratio’ in predicting outcomes of patients with locally advance rectal cancers
Nurullah Hamidi
International Journal of Surgery, 2013
View PDFchevron_right
The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer
Nick Pavlakis
Annals of surgery, 2016
View PDFchevron_right
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis
Francesca Cardella
Surgery, 2015
View PDFchevron_right
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer
Guido Mantovani
Scientific Reports, 2017
View PDFchevron_right
Platelet-lymphocyte ratio predicts poor prognosis in stage II / III colon and rectum cancer
şevki Pedük
Journal of health sciences and medicine, 2022
View PDFchevron_right
Neutrophil Lymphocyte Ratio (NLR) as a predictive factor radiological response of Neoadjuvant Chemotherapy (NAC) in Locally Advanced Rectal Cancer (LARC)
Tomy Lesmana
Bali Medical Journal, 2021
View PDFchevron_right
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
Vickie Baracos
British journal of cancer, 2011
View PDFchevron_right
Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer
Koya Hida
Scientific Reports, 2021
View PDFchevron_right
Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer
Sanja Stankovic
Disease Markers
View PDFchevron_right
The Systemic Inflammation Marker NLR as a Prognostic Factor in Complicated Colorectal Cancer
Rodica Birla
Journal of Biomedical Research & Environmental Sciences
View PDFchevron_right
Predictive and Prognostic Role of Neutrophil to Lymphocyte Ratio in Rectal Cancer: A Case Control Study with Propensity Score Analysis
Constantin Simiras
Chirurgia
View PDFchevron_right
Pretreatment Neutrophil/Lymphocytes Ratio in Non-Metastatic Colon Cancer as a Prognostic and Predictive Factor: A Retrospective Study
Ahmed Elzawawy
Journal of Cancer Therapy, 2023
View PDFchevron_right
Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO‐04 randomized phase 3 rectal cancer trial
Torsten Liersch
International Journal of Cancer, 2019
View PDFchevron_right
Prognostic role of platelet–lymphocyte ratio in colorectal cancer
Sonu Bhaskar
Medicine, 2016
View PDFchevron_right
The predictive value of neutrophil-lymphocyte ratio and mean platelet volume in patients with colorectal carcinoma
Mustafa Akar
Annals of Medical Research, 2020
View PDFchevron_right
The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers
James Park
PloS one, 2015
View PDFchevron_right
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
Alberto Zaniboni
Annals of Oncology, 2018
View PDFchevron_right
Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer
Hülagü Kargıcı
Turkish Journal of Medical Sciences, 2014
View PDFchevron_right
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis
SALLY MONTEIRO
World journal of surgical oncology, 2016
View PDFchevron_right
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer
Eiji Sunami
Radiation oncology (London, England), 2010
View PDFchevron_right
Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer
Teresa Fiuza
World Journal of Gastrointestinal Oncology
View PDFchevron_right
Platelet to Lymphocyte Ratio as a Potential Inflammatory Marker Predicting the Effect of Adjuvant Chemotherapy in Stage II Colorectal Cancer Patients
Dass Prakash
2020
View PDFchevron_right
Evaluation of Preoperative Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for their Predictive Value in Determining Short-Term Mortality in Patients with Operable Colorectal Cancers
ahmet karayiğit
Düzce Tıp Fakültesi Dergisi
View PDFchevron_right
High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
Barna Budai
Pathology and Oncology Research
View PDFchevron_right
Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery
Yuji Toiyama
International surgery, 2015
View PDFchevron_right
prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a
A. Zaniboni
View PDFchevron_right
The Role of Complete Blood Count Parameters in Patients with Colorectal Cancer
Danko Vrdoljak
Acta Clinica Croatica, 2018
View PDFchevron_right
The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis
Marco Giacometti
Annals of surgical oncology, 2014
View PDFchevron_right
Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting the Response to First Line Chemotherapy in Colorectal Cancer Patients with Synchronous Liver Metastases: A Retrospective Study
Yash Mathur
International Journal of Cancer Management
View PDFchevron_right
Abilities of Pre-Treatment Inflammation Ratios as Classification or Prediction Models for Patients with Colorectal Cancer
Sorana D. Bolboacă
Diagnostics
View PDFchevron_right
A comparison of the prognostic value of composite ratios and cumulative scores in patients with operable rectal cancer
Ross Dolan
Scientific Reports
View PDFchevron_right
Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Extramural Vascular Invasion (EMVI) in Locally Advanced Rectal Cancer
Lucjan Wyrwicz
Current Oncology, 2022
View PDFchevron_right